iiinova — where your digital self keeps evolving

Reposted by PopVax

Soham Sankaran @soh.am · 10/02/2025

I'm delighted to announce that PopVax (@popvax.com) has been awarded $2M by the US Biomedical Advanced Research and Development Authority (@bardagov.bsky.social) as a winner of the first stage of BARDA’s Patch Forward Prize for our seasonal influenza vaccine, along with our partner LTS. (1/12)

121

Reposted by PopVax

Soham Sankaran @soh.am · 03/01/2025

I've written a short piece about the potent, broadly-protective flu vaccines we're developing at PopVax to protect against both seasonal influenza strains and potential pandemic influenza such as the H5N1 strains currently circulating in cows chronicles.popvax.com/p/potent-bro... (thread below)

chronicles.popvax.com

Potent, broadly-protective flu vaccines to protect against potential pandemic influenza viruses such as H5N1

PopVax’s influenza vaccine designs elicit as much as 250x greater antibody titer against seasonal strains than existing approved flu vaccines, as well as robust antibody titer against H5N1

141

Reposted by PopVax

Soham Sankaran @soh.am · 23/12/2024

We now seek to apply our v/acc approach – vaccine accelerationism – to HCV, Strep A, and TB, three pathogens which collectively kill ~2 million people a year, and for which there are no existing effective vaccines. More in the video below: (4/4) youtu.be/OXxo49WrODQ

youtu.be

PopVax: Developing vaccines in India to save 1 million lives each year (Devcon SEA d/acc day talk)

YouTube video by PopVax

021

Reposted by PopVax

Soham Sankaran @soh.am · 23/12/2024

Our soon-to-be open sourced COVID-19 vaccine funded by Vitalik & Balvi is designed to protect against both current & future variants of SARS-CoV-2, aligning with the goals of d/acc. It will enter a Phase I trial in the US conducted & sponsored by NIAID (@niaidnews.bsky.social) in 2025. (3/4)

122

Reposted by PopVax

Soham Sankaran @soh.am · 23/12/2024

Vitalik, via his biosecurity and public health organization Balvi, was the first to believe in our vision of leveraging the 10x cost & speed advantages of doing R&D in India to develop fundamentally better, broader, safer, and more transparent vaccines, and is our largest funder. (2/4)

131

Reposted by PopVax

Soham Sankaran @soh.am · 23/12/2024

I recently spoke at Ethereum Devcon about PopVax (@popvax.com)'s work developing novel mRNA vaccines to save 1 million lives each year, as part of a series of talks organized by Vitalik Buterin (@vitalik.ca) around his d/acc vision – defensive, differential, and decentralized accelerationism. (1/4)

2198

Reposted by PopVax

Soham Sankaran @soh.am · 20/11/2024

PopVax (@popvax.com) is pleased to announce that NIAID (@niaidnews.bsky.social), part of the US National Institutes of Health, will conduct & sponsor the Phase I clinical trial of PopVax’s next-generation mRNA COVID-19 vaccine as part of the U.S. Government’s Project NextGen. (1/5)

131